Biohybrid Microrobot Enteric‐Coated Microcapsule for Oral Treatment of Colorectal Cancer

and EA alleviates the immunosuppressive microenvironment within the tumor. This promotes the maturation of dendritic cells and the polarization of macrophages toward the M1 phenotype, thereby reducing the proportion of regulatory T cells and enhancing the population of effector T cells.